News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
100 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22311)
Month
January (2433)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2495)
Day
1 (121)
2 (96)
3 (8)
5 (6)
6 (79)
7 (151)
8 (89)
9 (80)
10 (30)
13 (139)
14 (106)
15 (102)
16 (136)
17 (48)
19 (25)
20 (83)
21 (88)
22 (115)
23 (109)
24 (78)
26 (5)
27 (123)
28 (100)
29 (166)
30 (163)
31 (41)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
31
China
As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk
When signing a biotech licensing deal in China, experts say that pharma’s patent attorneys need to understand the geopolitical risk of the BIOSECURE Act.
July 28, 2026
·
7 min read
·
Annalee Armstrong
Press Releases
Akeso IO2.0 + ADC2.0 Strategy Makes Another Advancement: First Patient Dosed in Phase Ib/II Study of HER3 ADC (AK138D1) Combined with Ivonescimab in Lung Cancer
July 28, 2026
·
6 min read
Press Releases
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
July 28, 2026
·
5 min read
Press Releases
CroíValve Announces the Appointment of Jaime Wheeler as Chief Executive Officer
July 28, 2026
·
3 min read
Press Releases
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
July 28, 2026
·
7 min read
Press Releases
CENTENE ANNOUNCES BOARD OF DIRECTORS CHANGES
July 28, 2026
·
3 min read
Rare diseases
Oak Hill takes SPAC track to Nasdaq with Roche asset in tow
Oak Hill Bio is developing the antisense therapy rugonersen, which it licensed from Roche in 2025, for Angelman syndrome.
July 28, 2026
·
2 min read
·
Tristan Manalac
IPO
Apnimed eyes up to $160M IPO to prep for sleep apnea drug launch
If the offering closes, Apnimed will join the 2026 IPO class that has already far surpassed last year’s total.
July 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
July 28, 2026
·
10 min read
Press Releases
Lifecore Biomedical Signs Three New Customer Agreements
July 28, 2026
·
6 min read
1 of 10
Next
